ESR1 and breast carcinoma: Another hormone-activated transcription factor, the androgen receptor (AR), is more frequently expressed than ER in breast cancer, occurring in up to 95% of ER+ and ~ 20–30% of ER- primary tumors depending on detection method and criteria used to determine AR and ER positivity [5].